...
首页> 外文期刊>Radiation oncology >Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study
【24h】

Parotid gland-recovery after radiotherapy in the head and neck region - 36 months follow-up of a prospective clinical study

机译:头颈部区域放疗后腮腺的恢复-一项前瞻性临床研究的36个月随访

获取原文
           

摘要

Background The aim of the present study was to evaluate the recovery potential of the parotid glands after using either 3D-conformal-radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT) by sparing one single parotid gland. Methods Between 06/2002 and 10/2008, 117 patients with head and neck cancer were included in this prospective, non-randomised clinical study. All patients were treated with curative intent. Salivary gland function was assessed by measuring stimulated salivary flow at the beginning, during and at the end of radiotherapy as well as 1, 6, 12, 24, and 36 months after treatment. Measurements were converted to flow rates and normalized relative to rates before treatment. Mean doses (Dmean) were calculated from dose-volume histograms based on computed tomographies of the parotid glands. Results Patients were grouped according to the Dmean of the spared parotid gland having the lowest radiation exposure: Group I - Dmean 40 Gy (n = 36). 15/117 (13%) patients received IMRT. By using IMRT as compared to 3D-CRT the Dmean of the spared parotid gland could be significantly reduced (Dmean IMRT vs. 3D-CRT: 21.7 vs. 34.4 Gy, p < 0.001). The relative salivary flow rates (RFSR) as a function of the mean parotid dose after 24 and 36 months was in group I 66% and 74%, in group II 56% and 49%, and in group III 31% and 24%, respectively. Multiple linear regression analyses revealed that the parotid gland dose and the tumor site were the independent determinants 12 and 36 months after the end of RT. Patients of group I and II parotid gland function did recover at 12, 24, and 36 months after the end of RT. Conclusions If a Dmean < 26 Gy for at least one parotid gland can be achieved then this is sufficient to reach complete recovery of pre-RT salivary flow rates. The radiation volume which depends on tumor site did significantly impact on the Dmean of the parotids, and thus on the saliva flow and recovery of parotid gland.
机译:背景技术本研究的目的是通过保留单个腮腺来评估使用3D适形放射疗法(3D-CRT)或强度调制放射疗法(IMRT)后腮腺的恢复潜力。方法在06/2002年至10/2008年之间,该前瞻性非随机临床研究纳入了117例头颈癌患者。所有患者均已治愈。通过在放疗开始,过程中和结束时以及治疗后1、6、12、24和36个月测量刺激的唾液流量来评估唾液腺功能。将测量值转换为流速,并相对于治疗前的流速进行标准化。基于腮腺的计算机断层扫描,从剂量-体积直方图计算平均剂量(Dmean)。结果根据剩余的腮腺Dmean分组,将患者的辐射暴露最低:I组-Dmean 40 Gy(n = 36)。 15/117(13%)患者接受了IMRT。与3D-CRT相比,通过使用IMRT,可以显着降低剩余腮腺的Dmean(Dmean IMRT与3D-CRT:21.7 vs. 34.4 Gy,p <0.001)。在第24和36个月后,相对唾液流速(RFSR)作为腮腺平均剂量的函数,第一组分别为66%和74%,第二组为56%和49%,第三组为31%和24%,分别。多元线性回归分析显示,腮腺剂量和肿瘤部位是放疗结束后12个月和36个月的独立决定因素。 I组和II组腮腺功能患者在RT结束后的12、24和36个月时确实恢复了。结论如果至少一个腮腺的Dmean <26 Gy可以实现,则足以完全恢复RT前唾液流速。取决于肿瘤部位的辐射量确实显着影响腮腺的Dmean,从而影响唾液流量和腮腺的恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号